zepbound tirzepatide manufacturer eli lilly to Sell Directly to Consumers Without Insurance Coverage Company of the Year 2025:

The side effects observed were [31]: Nausea (24% of participants) Diarrhea (21%) Vomiting (14%) Constipation (8%) Dyspepsia (7%) Injection site reactions (3%) Cholelithiasis (less than 1%) Pancreatitis (less than 1%) Gastrointestinal side effects were the most common reason for discontinuation and their severity varied from mild to moderate

Patent protection limits direct competition Patents and other forms of regulatory exclusivity can prevent direct generic competition for a period of time

Treatment of Pregnant Women during the First Trimester There are no adequate and well-controlled clinical studies on the use of fluoxetine in pregnant women

22,23 In the liver, GLP-1RAs can also decrease hepatic gluconeogenesis and enhance glucose uptake, which can improve circulating glucose levels

Unsatisfactory Experiences No visible changes after several sessions

Most patients do not experience hair loss with the medication